About Josephine Schrøder

This author has not yet filled in any details.
So far Josephine Schrøder has created 12 blog entries.

Calluna Pharma

formely known as Arxx Therapeutics, develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis

Calluna Pharma2024-03-18T09:50:20+00:00
Go to Top